drug · small molecule
patient view →neflamapimod
Phase 2updated 2mo agoby $CRVO CervoMed Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2 (across all indications), with 6 investigational indications.
indications
indications
Alzheimer's Disease
targets
Mitogen-activated protein kinase 14
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that